SPOT-LIGHT HER2 CISH KIT

FDA Premarket Approval P050040 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Extension of the expiration date for a single lot of her-2 spt dna template (lot 63013).

DeviceSPOT-LIGHT HER2 CISH KIT
Generic NameChromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/neu Gene, Breast Cancer
ApplicantINVITROGEN CORPORATION
Date Received2012-06-01
Decision Date2012-07-06
PMAP050040
SupplementS003
Product CodeNYQ 
Advisory CommitteePathology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address INVITROGEN CORPORATION 3175 Staley Rd. grand Island, NY 14072

Supplemental Filings

Supplement NumberDateSupplement Type
P050040Original Filing
S003 2012-06-01 30-day Notice
S002 2011-03-01 Real-time Process
S001 2011-02-03 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.